Antibody-drug conjugates: strategies, experiences and challenges from the non-clinical development to clinical development in cancer treatment in France

被引：0
|
作者：
Burbank, M. G. [1 ]
Menoret, C. [1 ,2 ]
Lopes, S. [1 ]
Gazin, V. [1 ]
Boudali, L. [1 ]
机构：
[1] French Natl Agcy Med & Hlth Prod Safety ANSM, Oncol Div, St Denis, Reunion, France
[2] Francois Rabelais Univ, Tours, France
来源：
TOXICOLOGY LETTERS | 2018年 / 295卷
关键词：
D O I：
10.1016/j.toxlet.2018.06.965
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
P19-28
引用
收藏
页码：S228 / S229
页数：2
相关论文
共 50 条
  • [21] Importance and Considerations of Antibody Engineering in Antibody-Drug Conjugates Development from a Clinical Pharmacologist's Perspective
    Lucas, Andrew T.
    Moody, Amber
    Schorzman, Allison N.
    Zamboni, William C.
    ANTIBODIES, 2021, 10 (03)
  • [22] Antibody-drug conjugates in oncology. New strategies in development
    Beck, Alain
    Dumontet, Charles
    Joubert, Nicolas
    M S-MEDECINE SCIENCES, 2020, 35 (12): : 1043 - 1053
  • [23] Clinical Pharmacology of Antibody-Drug Conjugates
    Mahmood, Iftekhar
    ANTIBODIES, 2021, 10 (02)
  • [24] Antibody-drug conjugates (ADCs) for cancer therapy: Strategies, challenges, and successes
    Abdollahpour-Alitappeh, Meghdad
    Lotfinia, Majid
    Gharibi, Tohid
    Mardaneh, Jalal
    Farhadihosseinabadi, Behrouz
    Larki, Pegah
    Faghfourian, Babak
    Sepehr, Koushan Sineh
    Abbaszadeh-Goudarzi, Kazem
    Abbaszadeh-Goudarzi, Ghasem
    Johari, Behrooz
    Zali, Mohammad Reza
    Bagheri, Nader
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (05) : 5628 - 5642
  • [25] Regulatory considerations for clinical pharmacology during development of antibody-drug conjugates.
    Shord, Stacy Shifflett
    Schrieber, Sarah J.
    Zhao, Hong
    Booth, Brian
    Rahman, Nam Atiqur
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [26] Development of novel antibody-drug conjugates
    Takahashi, Shunji
    CANCER SCIENCE, 2021, 112 : 1026 - 1026
  • [27] Antibody-Drug Conjugates for Cancer Treatment
    Lambert, John M.
    Berkenblit, Anna
    ANNUAL REVIEW OF MEDICINE, VOL 69, 2018, 69 : 191 - 207
  • [28] Antibody-Drug Conjugates for the Treatment of Cancer
    Flygare, John A.
    Pillow, Thomas H.
    Aristoff, Paul
    CHEMICAL BIOLOGY & DRUG DESIGN, 2013, 81 (01) : 113 - 121
  • [29] Antibody-Drug Conjugates for Cancer Therapy: Chemistry to Clinical Implications
    Dan, Nirnoy
    Setua, Saini
    Kashyap, Vivek K.
    Khan, Sheema
    Jaggi, Meena
    Yallapu, Murali M.
    Chauhan, Subhash C.
    PHARMACEUTICALS, 2018, 11 (02)
  • [30] Antibody-drug conjugates in cancer therapy: mechanisms and clinical studies
    He, Jun
    Zeng, Xianghua
    Wang, Chunmei
    Wang, Enwen
    Li, Yongsheng
    MEDCOMM, 2024, 5 (08):
12345